最新更新 :
22/08/2024
Infostab
薬剤一覧
まとめ一覧
互換性の検索
Yサイト対応表
引用文献
研究チーム
valistab
ポスター
接続
スポンサー
作成者
ユーザーガイド
ニュースレター
Etoposide
化学構造
商品名
商品名、賦形剤は国、製薬会社ごとに異なることがあります
Eposin
イギリス, コロンビア, スウェーデン, ノルウェー, ベルギー, マレーシア, 南アフリカ共和国
Etocris
アルゼンチン, チリ, ペルー
Etolon
インド
Etomedac
ドイツ, ルクセンブルグ
Etonolver
ベネズエラ
Etoposide
オランダ, ギリシア, フランス
Etosid
インド, エジプト, マレーシア
Eunades
ブラジル
Euvaxon
アルゼンチン
Exitop
スウェーデン, ドイツ, フィンランド
Fytosid
インド, エジプト, マレーシア
Lastet
アラブ首長国連邦, イタリア, イラン, エジプト, トルコ, ハンガリー, ポーランド
Onkoposid
ドイツ
Riboposid
ドイツ
Sedol
ペルー
Toposin
オランダ
Tosuben
メキシコ
Vepesid
アイルランド, アメリカ, アーストラリア, イタリア, エジプト, オランダ, オーストリア, カナダ, ギリシア, クロアチア, コロンビア, サウジアラビア, スイス, スペイン, スロベニア, デンマーク, トルコ, ドイツ, ハンガリー, フィンランド, ベルギー, ポーランド, ルクセンブルグ, 南アフリカ共和国
Vepeside
チュニジア, モロッコ
引用文献 : Etoposide
形式
出版物
3
雑誌
Trissel LA, Martinez JF.
Compatibility of amifostine with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
57
雑誌
Mayron D, Gennaro AR.
Stability and compatibility of granisetron hydrochloride in IV solutions and oral liquids and during simulated Y-site injection with selected drugs.
Am J Health-Syst Pharm 1996 ; 53: 294-304.
81
雑誌
Trissel LA, Martinez JF.
Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 672-678.
84
雑誌
Trissel LA, Martinez JF.
Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 495-499.
85
雑誌
Trissel LA, Bready BB.
Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 1716-1719.
91
雑誌
Lober CA, Dollard PA.
Visual compatibility of gallium nitrate with selected drugs during Y-site injection.
Am J Hosp Pharm 1993 ; 50: 1208-1210.
99
雑誌
Trissel LA, Martinez JF.
Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
140
雑誌
Pearson SD, Trissel LA.
Leaching of diethylhexyl phthalate from polyvinyl chloride containers by selected drugs and formulation components.
Am J Hosp Pharm 1993 ; 50: 1405-1409.
150
雑誌
Aujoulat P, Coze C, Braguer D, Raybaud C.
Physicochemical compatibility of methotrexate with co-administered drugs during cancer chemotherapy regimens.
J Pharm Clin 1993 ; 12: 31-35.
152
雑誌
Chevrier R, Sautou V, Pinon V, Demecop F, Chopineau J.
Stability and compatibility of a mixture of the anti-cancer drugs etoposide, cytarabine and daunorubicine for infusion.
Pharm Acta Helv 1995 ; 70: 141-148.
161
雑誌
Barthes DM, Rochard EB, Pouliquen IJ, Rabouan SM, Courtois PY.
Stability and compatibility of etoposide in 0.9% sodium chloride injection in three containers.
Am J Hosp Pharm 1994 ; 51: 2706-2709.
169
雑誌
Trissel LA, Martinez JF.
Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1993 ; 50: 2359-2363.
182
雑誌
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 56-60.
184
雑誌
Stewart JT, Warren FW, King DT, Fox JL.
Stability of ondansetron hydrochloride and five antineoplasic medications.
Am J Health-Syst Pharm 1996 ; 53: 1297-1300.
244
雑誌
Trissel LA, Martinez JF.
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1907-1913.
249
雑誌
Trissel LA, Martinez JF.
Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1996 ; 53: 1041-1045.
251
雑誌
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 2708-2713.
307
雑誌
Trissel LA, Martinez JF.
Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1792-1799.
331
雑誌
Marquardt ED.
Visual compatibility of hydroxyzine hydrochloride with various antineoplasic agents.
Am J Hosp Pharm 1988 ; 45: 2127.
334
雑誌
Trissel LA, Tramonte SM, Grilley BJ.
Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 988-992.
335
雑誌
Trissel LA, Bready BB, Kwan JW, Santiago NM.
Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 402-406.
417
雑誌
Stewart CF, Hampton EM.
Stability of cisplatin and etoposide in intravenous admixtures.
Am J Hosp Pharm 1989 ; 46: 1400-1404.
482
雑誌
Beijnen JH, Beijnen-Bandhoe U, Dubbelman AC, Van Gijn R, Underberg WJM.
Chemical and physical stability of etoposide and teniposide in commonly used infusion fluids.
J Parenter Sci Technol 1991 ; 45: 108-112.
491
雑誌
Turowski RC, Durthaler JM.
Visual compatibility of idarubicin hydrochloride with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 2181-2184.
492
雑誌
Trissel LA, Parks NPT, Santiago NM.
Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 2186-2189.
504
雑誌
Hamon M, Plas-Remoissenet D, Kubab-Alajati S.
Etude de la stabilité dans des solutions diluées destinées à la perfusion de deux antimitotiques dérivés de la podophyllotoxine : l’étoposide (VP 16), le téniposide (VM 26).
Sci Tech Pharm 1987 ; 3: 33-40.
643
雑誌
Seargeant LE, Kobrinsky NL, Sus CJ, Nazeravich DR.
In vitro stability and compatibility of daunorubicin, cytarabine, and etoposide.
Cancer Treat Rep 1987 ; 71: 1189-1192.
905
雑誌
Trissel LA, Martinez JF.
Screening teniposide for Y-site physical incompatibilities.
Hosp Pharm 1994 ; 29: 1010-1017.
1026
雑誌
Mayron D, Gennaro AR.
Stability and compatibility of topotecan hydrochloride with selected drugs.
Am J Health-Syst Pharm 1999 ; 56: 875-881.
1033
雑誌
Wolfe JL, Thoma LA, Du C, Goldspiel BR, Gallelli JF, Grimes GJ, Potti GK.
Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide in 0.9% sodium chloride injection.
Am J Health-Syst Pharm 1999 ; 56: 985-989.
1423
雑誌
Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
1496
雑誌
Trissel LA, Martinez JF, Gilbert DL.
Screening cladribine for Y-site physical compatibility with selected drugs.
Hosp Pharm 1996 ; 31: 1425-1428.
1520
実験
Etude de stabilité des médicaments en Ecoflac®
B Braun 2001
1613
雑誌
Lepage R, Walker SE, Godin J.
Stability and compatibility of etoposide in normal saline.
Can J Hosp Pharm 2000 ; 53: 338-345.
1722
雑誌
Gras C, Sautou-Miranda V, Bagel-Boithias S, Brigas F, Chopineau J.
Compatibility of etoposide solution with polyvinyl chloride and low density polyethylene containers and its stability in different storage conditions.
EJHP 2002 ; 2: 33-40.
1730
雑誌
Björkman S, Roth B.
Chemical compatibility of mitoxantrone and etoposide (VP-16).
Act Pharm Nord 1991 ; 3: 251.
1819
雑誌
Demoré B, Vigneron J, Perrin A, Hoffman MA, Hoffman M.
Leaching of diethyl hexyl phtalate from polyvinyl chloride bags into intravenous etoposide solution.
J Clin Pharm Ther 2002 ; 27: 139-142.
1895
雑誌
Bourdeaux D, Sautou-Miranda V, Bagel-Boithias S, Boyer A, Chopineau J.
Analysis by liquid chromatography and infrared spectrometry of di(2-ethylhexyl)phtalate released by multilayer infusion tubing.
J Pharm Biomed Anal 2004 ; 35: 57-64.
1984
雑誌
Bagel-Boithias S, Sautou-Miranda V, Bourdeaux D, Tramier V, Boyer A, Chopineau J.
Leaching of diethylhexyl phtalate from multilayer tubing into etoposide infusion solutions.
Am J Health-Syst Pharm 2005 ; 62: 182-188.
2108
雑誌
Trusley C, Kupiec TC, Trissel LA.
Compatibility of micafungin injection with other drugs during simulated Y-site co-administration.
Int J Pharm Compound 2006 ; 10: 230-232.
2167
雑誌
Joel SP, Clark PI, Slevin ML.
Stability of the iv and oral formulations of etoposide in solution.
Cancer Chemother Pharmacol 1995 ; 37, 1: 117-124.
3574
実験
Ondansetron - Résumé des caractéristiques du produit
Accord Healthcare France SAS 2013
3670
雑誌
Sewell G, Massimini M.
Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system.
EJOP 2014 ; 8, 3: 26-30.
4024
ポスター
Sadou Yaye H, Rieber Z, HassaniI L, Hoffmann-Martinot C, Babiard M, Aouti H, Bellanger A, Tilleul P.
Pénurie mondiale d'Etopophos et conséquences pratiques : Intérêt des études de stabilité dans le choix d'un générique.
SFPO Congress 2017 - Nantes 2017
4125
雑誌
D'Huart E, Vigneron J, Lider P, Demoré B.
Physicochemical stability of etoposide diluted at range concentrations between 0.38 and 1.75 mg/mL in polyolefin bags.
EJHP 2020 ; 27, 1: 43-48.
4304
雑誌
Klasen K, Kessari R, Mercier L, Valade C, Grill J, Desmaris R, Paci A.
Stability of Etoposide Solutions in Disposable Infusion Devices for Day Hospital Cancer Practices.
Drugs R D 2014 ; 14:13?23.
4352
雑誌
Li J, Yao C, Xu Y, Ping P, Yin H, Sun Y.
In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag.
J Clin Pharm Ther 2019 ; 44: 875-882.
4369
雑誌
Sadou Yayé H, Hassani L, Secrétan PH, Babiard M, Aouati H, Bellanger A, Tilleul P, Yagoubi N, Do B, Rietveld I.
Physical and chemical stability of a generic etoposide formulation as an alternative to etoposide phosphate
J Pharm Biomed Anal 2020 ;178:112896
Mentions Légales